Allergan News, Allergan Quote, AGN Quote

Allergan (NY:AGN) Delayed: 193.02 --0 (-0%)

Prev. Close

$193.02

Open

$15.33

52 Wk High

$322.68

52 Wk Low

$186.34

Day High

$193.02

Day Low

$193.02

P/E

45.96

EPS

$4.20

Volume

43,377

Friends, Peers and Foes (?): AEG, AGNPF, AGW0, ALG APD (more...)

Apr 24, 2024 07:47 AM Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
Apr 11, 2024 07:00 AM Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
Apr 10, 2024 03:05 PM Form D Algernon Pharmaceuticals
Apr 10, 2024 06:25 AM Form 6-K AEGON LTD. For: Apr 10
Apr 9, 2024 06:10 AM Form 6-K AEGON LTD. For: Apr 09
Apr 4, 2024 09:49 AM Form IRANNOTICE AEGON LTD.
Apr 4, 2024 09:46 AM Form 6-K AEGON LTD. For: Apr 04
Apr 4, 2024 07:32 AM Form 20-F AEGON LTD. For: Dec 31
Apr 1, 2024 07:00 AM Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Mar 27, 2024 12:05 PM Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position

Entities mentioned with AGN